Biotechnology and pharmaceutical industry veteran and GBS Ventures partner, Dr Andrew Baker, died on Sunday March 18 from cancer. [ + ]

A group of buyers including Elliott Management have purchased $23m worth of CDIs and shares in ASX-listed US medical device company REVA Medical (ASX:RVA). [ + ]

QRxPharma (ASX:QRX) has closed a deal to license its dual-opioid pain product, MoxDuo IR, to pharmaceutical company Actavis. [ + ]

Professor Emily Hilder, from the University of Tasmania, has won the prestigious LCGC 2012 Emerging Leader in Chromatography Award. This is the first time the award has been presented to an Australian researcher and the first time to a female researcher. [ + ]

Dual-listed biotech Bioniche (ASX:BNC) has negotiated to receive a $19m, non-dilutive finance facility from the USA's Capital Royalty. [ + ]

The $10 million Asia-Pacific Centre for Neuromodulation will focus on deep brain stimulation and seek to become an international hub for brain research. [ + ]

Congratulations to Carla Mathews from Austin Health, who has won an iPad after completing the recent What’s New in LAB Technology survey. [ + ]

LBT Innovations (ASX:LBT) has filed applications for international patents for its second invention, the Automated Plate Assessment System (APAS). [ + ]

Pharmaxis (ASX:PXS) has been notified that it should soon receive approval for its marketing application to sell its Bronchitol cystic fibrosis treatment in the EU. [ + ]

Researchers have found the STAT3 gene is central to proper immune function, raising hope of new medications to treat immunodeficient and autoimmune disorders. [ + ]

Contract medical company IQnovate has signed a memorandum of understanding with JH Biotech Australasia to commercialise and extract research and development efficiencies related to a range of biotechnology products, including ones suitable for animal nutrition. [ + ]

The TGA has granted manufacturing approval for Prima BioMed (ASX:PRR) to produce its CVac ovarian cancer vaccine in Australia, for use in a major clinical trial. [ + ]

Contract medical company IQnovate (NSX:IQN) has signed a preliminary agreement to provide commercialisation services for JH Biotech Australasia. [ + ]

Drug delivery company Phosphagenics (ASX:POH) has secured an agreement to supply its BioElixia skincare products to a Korean distributor. [ + ]

The University of Queensland and the Queensland Institute of Medical Research have entered a joint research partnership to manage and fund the Australian Infectious Diseases Research Centre. [ + ]